Other languages Black Diamond Therapeutics, Inc.

Equities

BDTX

US09203E1055

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-26 EDT			5-day change	1st Jan Change
5.89 ^USD	+15.26%		+11.98%	+109.61%

04-11	Black Diamond Therapeutics, Inc. Announces Board and Committee Changes	CI
04-08	Wedbush Adjusts Price Target on Black Diamond Therapeutics to $16 From $10 After Market Confirmation for Drug, Maintains Outperform Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Black Diamond Therapeutics, Inc. Announces Board and Committee Changes	04-11
Black Diamond Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-12
Black Diamond Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-12
Black Diamond Therapeutics, Inc. Announces Resignation of Rajeev Shah from Board of Directors, Including as A Member of the Audit Committee of the Board	01-18
Black Diamond Therapeutics, Inc. Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM	12-13
Black Diamond Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-06
Black Diamond Therapeutics, Inc. Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535	23-10-14
Black Diamond Therapeutics, Inc. Announces Management Changes	23-09-18
Black Diamond Therapeutics, Inc. Announces Chief Executive Officer Changes	23-09-18
Black Diamond Therapeutics, Inc. Doses First Patients in Phase 1 Clinical Trial Expansion Cohorts Evaluating BDTX-1535 in Patients with Intrinsic Driver and Acquired Resistance EGFR Mutation Positive Non-Small Cell Lung Cancer	23-09-11
Black Diamond Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11
BB Biotech dimezza la perdita trimestrale e dice addio a Piazza Affari	23-07-21
Sector Update: Health Care Stocks Steady Premarket Monday	23-07-10
Black Diamond Therapeutics Discloses Institutional Shareholder Equity Stake Expansion; Shares Jump Premarket	23-07-10
Black Diamond Therapeutics Prices $75 Million Common Stock Offering	23-06-30
Top Premarket Decliners	23-06-29
Black Diamond Therapeutics Launches $75 Million Stock Offering; Shares Drop After-Hours	23-06-28
Insider Sell: Black Diamond Therapeutics	23-06-28
Sector Update: Health Care Stocks Softer Late Tuesday	23-06-27
Sector Update: Health Care Stocks Easing Tuesday Afternoon	23-06-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Black Diamond Therapeutics, Inc.

Equities

BDTX

US09203E1055

Other languages

Filters